Literature DB >> 5870

Cytological investigation of Rickettsia tsutsugamushi infection of mice with different allotypic susceptibility to the agent.

I N Kokorin, C D Kyet, N G Kekcheeva, E D Miskarova.   

Abstract

Cytological and cytochemical studies on Swiss and random-bred white mice susceptible to Rickettsia tsutsugamushi infection as well as resistant C57 Black 6 and CBA mice revealed a clear-cut relationship between the severity of infection and the pattern of macrophage reaction. In highly susceptible mice the fatal infection was accompanied by death of macrophages and necrotisation of the peritoneal exudate cells. The resistant mice showed no clinical signs but developed an intensive macrophage reaction, and the main mass of the inoculated rickettsiae died at the inoculation site, the macrophages remaining viable. Phagocytosis and digestion of rickettsiae were accompanied by markedly increased activities of hydrolytic and oxidizing-reducing enzymes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5870

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  4 in total

1.  Experimental infection of mouse peritoneal mesothelium with scrub typhus rickettsiae: an ultrastructural study.

Authors:  E P Ewing; A Takeuchi; A Shirai; J V Osterman
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  Comparative susceptibility to mouse interferons of Rickettsia tsutsugamushi strains with different virulence in mice and of Rickettsia rickettsii.

Authors:  B Hanson
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

3.  Characterization of factors determining Rickettsia tsutsugamushi pathogenicity for mice.

Authors:  M G Groves; D J Kelly
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

4.  Host defenses in experimental scrub typhus: genetics of natural resistance to infection.

Authors:  M G Groves; J V Osterman
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.